MedTrace Logo

Evaluation of the Effects of Different Positions Given During Antenatal Electro-Fetal Monitoring

NCT05863156 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 305

Last updated 2025-03-03

Study results available
· View outcomes & findings →

Summary

The objective of this study was to assess the effects of different maternal positions during electronic fetal monitoring (EFM) on maternal and fetal health outcomes. The study was conducted between December 2021 and January 2023 in a maternity hospital in Istanbul, employing a randomized controlled trial design. A total of 240 pregnant women were randomized into three groups: 60 participants were assigned to the right-side lying position (intervention 1), 60 to the semi-sitting position (intervention 2), and 120 to the left-side lying.

Maternal systolic blood pressure, body temperature, and pulse rate were measured before, during, and after the EFM procedure. Research data were collected through the Information Form and the General Comfort Scale-Short Form.

Conditions

  • Fetal Monitoring
  • Patient Comfort
  • Maternal Health

Interventions

DIAGNOSTIC_TEST

Right side lying position

In the study, 60 participants were placed in the right side lying position (intervention 1)

DIAGNOSTIC_TEST

Semi Fowler

In the study, 60 participants in the semi-sitting position (intervention 2)

DIAGNOSTIC_TEST

left side lying position

In the study, 120 participants in the left side lying position (control group).

Sponsors & Collaborators

  • Uskudar University

    lead OTHER

Principal Investigators

  • TUĞBA YILMAZ ESENCAN · Uskudar University

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
49 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-12-30
Primary Completion
2022-07-30
Completion
2022-11-30

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05863156 on ClinicalTrials.gov